Search research articles
Contact Us
Filters
Showing results (31-40 of 514) with videos related to
Page
of 52
Sort By:
International Journal of Clinical Oncology
|
April 25, 2009
Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
Qian Shi, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2008
New lessons from "old" chemotherapy in colorectal cancer
Axel Grothey, Daniel J Sargent
Future Medicinal Chemistry
|
June 2, 2012
From isolated hypotheses to connected practical studies: statisticians' role in a seamless targeted therapy development
Qian Shi, Daniel J Sargent
The Journal of Organic Chemistry
|
October 29, 2010
Attempts to find new antimalarials; some heterocyclic sulfanilamide derivatives
L J SARGENT, L SMALL
The New England Journal of Medicine
|
July 23, 2004
New treatment options for colorectal cancer
Charles Erlichman, Daniel J Sargent
Clinical Advances in Hematology & Oncology : H&O
|
September 10, 2015
Key statistical concepts in cancer research
Qian Shi, Daniel J Sargent
The New England Journal of Medicine
|
September 8, 2001
Refining multimodal therapy for rectal cancer
H Nelson, D J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2005
FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer
Axel Grothey, Daniel J Sargent
The Journal of Organic Chemistry
|
October 29, 2010
Attempts to find new antimalarials; studies in the acridine series; 9-N-heterocyclic acridines and 9-acridylsulfanilamides
L J SARGENT, L SMALL
The Journal of Organic Chemistry
|
March 19, 2010
Studies on the acridine series; dialkylaminoalkylamines derived from 5- and 7-Bz-methoxy-9-chloro-1,2,3,4-tetrahydroacridines
L J SARGENT, L SMALL
Page
of 52
Search research articles
Search
Showing results (31-40 of 514) with videos related to
Sort By:
Page
of 52
International Journal of Clinical Oncology
|
April 25, 2009
Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
Qian Shi, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2008
New lessons from "old" chemotherapy in colorectal cancer
Axel Grothey, Daniel J Sargent
Future Medicinal Chemistry
|
June 2, 2012
From isolated hypotheses to connected practical studies: statisticians' role in a seamless targeted therapy development
Qian Shi, Daniel J Sargent
The Journal of Organic Chemistry
|
October 29, 2010
Attempts to find new antimalarials; some heterocyclic sulfanilamide derivatives
L J SARGENT, L SMALL
The New England Journal of Medicine
|
July 23, 2004
New treatment options for colorectal cancer
Charles Erlichman, Daniel J Sargent
Clinical Advances in Hematology & Oncology : H&O
|
September 10, 2015
Key statistical concepts in cancer research
Qian Shi, Daniel J Sargent
The New England Journal of Medicine
|
September 8, 2001
Refining multimodal therapy for rectal cancer
H Nelson, D J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2005
FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer
Axel Grothey, Daniel J Sargent
The Journal of Organic Chemistry
|
October 29, 2010
Attempts to find new antimalarials; studies in the acridine series; 9-N-heterocyclic acridines and 9-acridylsulfanilamides
L J SARGENT, L SMALL
The Journal of Organic Chemistry
|
March 19, 2010
Studies on the acridine series; dialkylaminoalkylamines derived from 5- and 7-Bz-methoxy-9-chloro-1,2,3,4-tetrahydroacridines
L J SARGENT, L SMALL
Page
of 52